A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205.

Hotte, Sebastien J

A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205. [electronic resource] - Clinical genitourinary cancer 06 2019 - 201-208.e1 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

1938-0682

10.1016/j.clgc.2019.03.005 doi


Aged
Aged, 80 and over
Androstenes--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Canada
Disease Progression
Gonanes--administration & dosage
Humans
Male
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Neoplastic Cells, Circulating--drug effects
PTEN Phosphohydrolase--genetics
Prostatic Neoplasms, Castration-Resistant--drug therapy
Survival Analysis
Treatment Outcome